Comparison of genetic alterations in neuroendocrine tumors: Frequent loss of chromosome 18 in ileal carcinoid tumors

Gordon G. Wang, James C. Yao, Samidha Worah, Jill A. White, Rene Luna, Tsung Teh Wu, Stanley R. Hamilton, Asif Rashid

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Carcinoid tumors and pancreatic endocrine tumors are uncommon neuroendocrine neoplasms, and their genetic alterations are not well characterized. These tumors have site-specific differences in neuroendocrine characteristics, clinical course and genetic alterations. We compared clinicopathological features and loss of heterozygosity of chromosomes 11q, 16q and 18, and BRAF gene mutations in 47 patients with neuroendocrine tumors including 16 with pancreatic endocrine tumors, 15 with nonileal carcinoid tumors and 16 with ileal carcinoid tumors. Patients with carcinoid tumors had more frequent history of alcohol consumption compared to patients with pancreatic endocrine tumors (P = 0.02), and patients with ileal carcinoid tumors more frequently had liver metastasis compared to patients with nonileal carcinoid tumors and pancreatic endocrine tumors (P = 0.02). Allelic loss of chromosome 11q was present in 21% of tumors, chromosome 16q in 13%, and chromosome 18 in 30%. These alterations differed with the anatomical subsite of tumor: allelic loss of chromosome 18 was present in 69% of ileal carcinoid tumors, 13% of nonileal carcinoid tumors and 6% of pancreatic endocrine tumors (P = 0.001). In contrast to pancreatic endocrine tumors and nonileal carcinoid tumors, all 11 ileal tumors with loss of chromosome 18 had complete loss of both chromosomal arms. No BRAF mutations were identified. Complete allelic loss of chromosome 18 was associated with smaller tumor size (P = 0.02). Our study indicates that genetic alterations vary by tumor subsite and clinicopathologic features, and ileal carcinoid tumors have distinctive clinicopathologic and genetic profiles.

Original languageEnglish (US)
Pages (from-to)1079-1087
Number of pages9
JournalModern Pathology
Volume18
Issue number8
DOIs
StatePublished - Aug 2005
Externally publishedYes

Fingerprint

Chromosomes, Human, Pair 18
Neuroendocrine Tumors
Carcinoid Tumor
Neoplasms
Loss of Heterozygosity
Chromosomes
Chromosomes, Human, Pair 21
Mutation
Alcohol Drinking

Keywords

  • Allelic loss
  • BRAF mutations
  • Carcinoid tumor
  • Pancreatic endocrine tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Wang, G. G., Yao, J. C., Worah, S., White, J. A., Luna, R., Wu, T. T., ... Rashid, A. (2005). Comparison of genetic alterations in neuroendocrine tumors: Frequent loss of chromosome 18 in ileal carcinoid tumors. Modern Pathology, 18(8), 1079-1087. https://doi.org/10.1038/modpathol.3800389

Comparison of genetic alterations in neuroendocrine tumors : Frequent loss of chromosome 18 in ileal carcinoid tumors. / Wang, Gordon G.; Yao, James C.; Worah, Samidha; White, Jill A.; Luna, Rene; Wu, Tsung Teh; Hamilton, Stanley R.; Rashid, Asif.

In: Modern Pathology, Vol. 18, No. 8, 08.2005, p. 1079-1087.

Research output: Contribution to journalArticle

Wang, GG, Yao, JC, Worah, S, White, JA, Luna, R, Wu, TT, Hamilton, SR & Rashid, A 2005, 'Comparison of genetic alterations in neuroendocrine tumors: Frequent loss of chromosome 18 in ileal carcinoid tumors', Modern Pathology, vol. 18, no. 8, pp. 1079-1087. https://doi.org/10.1038/modpathol.3800389
Wang, Gordon G. ; Yao, James C. ; Worah, Samidha ; White, Jill A. ; Luna, Rene ; Wu, Tsung Teh ; Hamilton, Stanley R. ; Rashid, Asif. / Comparison of genetic alterations in neuroendocrine tumors : Frequent loss of chromosome 18 in ileal carcinoid tumors. In: Modern Pathology. 2005 ; Vol. 18, No. 8. pp. 1079-1087.
@article{ec9dd36936b14cf6981855ea36d95d1d,
title = "Comparison of genetic alterations in neuroendocrine tumors: Frequent loss of chromosome 18 in ileal carcinoid tumors",
abstract = "Carcinoid tumors and pancreatic endocrine tumors are uncommon neuroendocrine neoplasms, and their genetic alterations are not well characterized. These tumors have site-specific differences in neuroendocrine characteristics, clinical course and genetic alterations. We compared clinicopathological features and loss of heterozygosity of chromosomes 11q, 16q and 18, and BRAF gene mutations in 47 patients with neuroendocrine tumors including 16 with pancreatic endocrine tumors, 15 with nonileal carcinoid tumors and 16 with ileal carcinoid tumors. Patients with carcinoid tumors had more frequent history of alcohol consumption compared to patients with pancreatic endocrine tumors (P = 0.02), and patients with ileal carcinoid tumors more frequently had liver metastasis compared to patients with nonileal carcinoid tumors and pancreatic endocrine tumors (P = 0.02). Allelic loss of chromosome 11q was present in 21{\%} of tumors, chromosome 16q in 13{\%}, and chromosome 18 in 30{\%}. These alterations differed with the anatomical subsite of tumor: allelic loss of chromosome 18 was present in 69{\%} of ileal carcinoid tumors, 13{\%} of nonileal carcinoid tumors and 6{\%} of pancreatic endocrine tumors (P = 0.001). In contrast to pancreatic endocrine tumors and nonileal carcinoid tumors, all 11 ileal tumors with loss of chromosome 18 had complete loss of both chromosomal arms. No BRAF mutations were identified. Complete allelic loss of chromosome 18 was associated with smaller tumor size (P = 0.02). Our study indicates that genetic alterations vary by tumor subsite and clinicopathologic features, and ileal carcinoid tumors have distinctive clinicopathologic and genetic profiles.",
keywords = "Allelic loss, BRAF mutations, Carcinoid tumor, Pancreatic endocrine tumor",
author = "Wang, {Gordon G.} and Yao, {James C.} and Samidha Worah and White, {Jill A.} and Rene Luna and Wu, {Tsung Teh} and Hamilton, {Stanley R.} and Asif Rashid",
year = "2005",
month = "8",
doi = "10.1038/modpathol.3800389",
language = "English (US)",
volume = "18",
pages = "1079--1087",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Comparison of genetic alterations in neuroendocrine tumors

T2 - Frequent loss of chromosome 18 in ileal carcinoid tumors

AU - Wang, Gordon G.

AU - Yao, James C.

AU - Worah, Samidha

AU - White, Jill A.

AU - Luna, Rene

AU - Wu, Tsung Teh

AU - Hamilton, Stanley R.

AU - Rashid, Asif

PY - 2005/8

Y1 - 2005/8

N2 - Carcinoid tumors and pancreatic endocrine tumors are uncommon neuroendocrine neoplasms, and their genetic alterations are not well characterized. These tumors have site-specific differences in neuroendocrine characteristics, clinical course and genetic alterations. We compared clinicopathological features and loss of heterozygosity of chromosomes 11q, 16q and 18, and BRAF gene mutations in 47 patients with neuroendocrine tumors including 16 with pancreatic endocrine tumors, 15 with nonileal carcinoid tumors and 16 with ileal carcinoid tumors. Patients with carcinoid tumors had more frequent history of alcohol consumption compared to patients with pancreatic endocrine tumors (P = 0.02), and patients with ileal carcinoid tumors more frequently had liver metastasis compared to patients with nonileal carcinoid tumors and pancreatic endocrine tumors (P = 0.02). Allelic loss of chromosome 11q was present in 21% of tumors, chromosome 16q in 13%, and chromosome 18 in 30%. These alterations differed with the anatomical subsite of tumor: allelic loss of chromosome 18 was present in 69% of ileal carcinoid tumors, 13% of nonileal carcinoid tumors and 6% of pancreatic endocrine tumors (P = 0.001). In contrast to pancreatic endocrine tumors and nonileal carcinoid tumors, all 11 ileal tumors with loss of chromosome 18 had complete loss of both chromosomal arms. No BRAF mutations were identified. Complete allelic loss of chromosome 18 was associated with smaller tumor size (P = 0.02). Our study indicates that genetic alterations vary by tumor subsite and clinicopathologic features, and ileal carcinoid tumors have distinctive clinicopathologic and genetic profiles.

AB - Carcinoid tumors and pancreatic endocrine tumors are uncommon neuroendocrine neoplasms, and their genetic alterations are not well characterized. These tumors have site-specific differences in neuroendocrine characteristics, clinical course and genetic alterations. We compared clinicopathological features and loss of heterozygosity of chromosomes 11q, 16q and 18, and BRAF gene mutations in 47 patients with neuroendocrine tumors including 16 with pancreatic endocrine tumors, 15 with nonileal carcinoid tumors and 16 with ileal carcinoid tumors. Patients with carcinoid tumors had more frequent history of alcohol consumption compared to patients with pancreatic endocrine tumors (P = 0.02), and patients with ileal carcinoid tumors more frequently had liver metastasis compared to patients with nonileal carcinoid tumors and pancreatic endocrine tumors (P = 0.02). Allelic loss of chromosome 11q was present in 21% of tumors, chromosome 16q in 13%, and chromosome 18 in 30%. These alterations differed with the anatomical subsite of tumor: allelic loss of chromosome 18 was present in 69% of ileal carcinoid tumors, 13% of nonileal carcinoid tumors and 6% of pancreatic endocrine tumors (P = 0.001). In contrast to pancreatic endocrine tumors and nonileal carcinoid tumors, all 11 ileal tumors with loss of chromosome 18 had complete loss of both chromosomal arms. No BRAF mutations were identified. Complete allelic loss of chromosome 18 was associated with smaller tumor size (P = 0.02). Our study indicates that genetic alterations vary by tumor subsite and clinicopathologic features, and ileal carcinoid tumors have distinctive clinicopathologic and genetic profiles.

KW - Allelic loss

KW - BRAF mutations

KW - Carcinoid tumor

KW - Pancreatic endocrine tumor

UR - http://www.scopus.com/inward/record.url?scp=24044507296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044507296&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800389

DO - 10.1038/modpathol.3800389

M3 - Article

C2 - 15920555

AN - SCOPUS:24044507296

VL - 18

SP - 1079

EP - 1087

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 8

ER -